Trials / Completed
CompletedNCT02567539
Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma
Phase II Study of Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is aimed to evaluate efficacy and safety of re-irradiation for patients with recurrent high grade gliomas after other treatment.
Detailed description
Investigators designed this study of a re-irradiation with single radiosurgery or hypofractionated intensity modulated radiation therapy (IMRT) with or without temozolomide. Objective of the study is evaluating efficacy and safety of re-irradiation for patients with recurrent high grade gliomas after other treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | IMRT with or without radiosensitive therapy | Re-irradiation with hypofractionated intensity modulated radiation therapy (IMRT), using VMAT RapidArc |
| DRUG | Radiosensitive therapy | Radiosensitive therapy with Temozolomide |
Timeline
- Start date
- 2015-05-27
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2015-10-05
- Last updated
- 2022-09-15
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02567539. Inclusion in this directory is not an endorsement.